Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Serplulimab Plus Bevacizumab and Chemotherapy in NSCLC Patients With Brain Metastases [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 study evaluating the safety and efficacy of serplulimab plus bevacizumab and chemotherapy in non-small cell lung cancer patients with brain metastases…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Non-small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Serplulimab (serplulimab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Non-small Cell Lung Cancer Stage II, Bevacizumab | Phase 2, Phase 3 | Status: COMPLETED